$0.31 EPS Expected for MedEquities Realty Trust, Inc. (MRT); Weatherstone Capital Management Has Lowered Jpmorgan Chase & Co (JPM) Stake By $317,585

February 2, 2018 - By wolcottdaily

Weatherstone Capital Management decreased Jpmorgan Chase & Co (JPM) stake by 50.53% reported in 2017Q3 SEC filing. Weatherstone Capital Management sold 3,343 shares as Jpmorgan Chase & Co (JPM)’s stock declined 6.04%. The Weatherstone Capital Management holds 3,273 shares with $313,000 value, down from 6,616 last quarter. Jpmorgan Chase & Co now has $397.08 billion valuation. The stock decreased 0.80% or $0.93 during the last trading session, reaching $115.94. About 6.50 million shares traded. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since February 2, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Analysts expect MedEquities Realty Trust, Inc. (NYSE:MRT) to report $0.31 EPS on February, 26.They anticipate $0.04 EPS change or 14.81% from last quarter’s $0.27 EPS. MRT’s profit would be $9.84M giving it 8.69 P/E if the $0.31 EPS is correct. After having $0.29 EPS previously, MedEquities Realty Trust, Inc.’s analysts see 6.90% EPS growth. It closed at $10.78 lastly. It is down 0.00% since February 2, 2017 and is . It has underperformed by 16.70% the S&P500.

MedEquities Realty Trust is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The company has market cap of $342.33 million. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios. It has a 26.88 P/E ratio. MedEquities' strategy is to become an integral capital partner with high-quality and growth-oriented facility providers of healthcare services on a nationwide basis, primarily through net-leased real estate investment.

Among 7 analysts covering MedEquities Realty (NYSE:MRT), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. MedEquities Realty had 7 analyst reports since October 24, 2016 according to SRatingsIntel. The stock of MedEquities Realty Trust, Inc. (NYSE:MRT) has “Outperform” rating given on Monday, October 24 by Raymond James. FBR Capital initiated it with “Outperform” rating and $14 target in Monday, October 24 report. Citigroup initiated MedEquities Realty Trust, Inc. (NYSE:MRT) on Monday, October 24 with “Neutral” rating. JP Morgan initiated the shares of MRT in report on Monday, October 24 with “Neutral” rating. The firm has “Overweight” rating by KeyBanc Capital Markets given on Monday, November 14. The firm has “Outperform” rating given on Monday, October 24 by RBC Capital Markets. The stock of MedEquities Realty Trust, Inc. (NYSE:MRT) earned “Mkt Outperform” rating by JMP Securities on Monday, October 24.

Investors sentiment decreased to 0.91 in Q3 2017. Its down 0.28, from 1.19 in 2017Q2. It worsened, as 65 investors sold JPM shares while 767 reduced holdings. 125 funds opened positions while 635 raised stakes. 2.50 billion shares or 7.05% less from 2.69 billion shares in 2017Q2 were reported. Pineno Levin & Ford Asset Mngmt Inc holds 0.1% or 2,226 shares in its portfolio. Salem Counselors, North Carolina-based fund reported 160,078 shares. Suffolk Capital Mngmt Ltd holds 1.22% or 97,053 shares. Pggm owns 2.41 million shares for 1.14% of their portfolio. Fortaleza Asset Management Inc holds 6,330 shares or 1.11% of its portfolio. Moreover, Eagleclaw Cap Managment Ltd Com has 2.48% invested in JPMorgan Chase & Co. (NYSE:JPM) for 45,944 shares. Mitsubishi Ufj Secs Hldgs Ltd has invested 0.92% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Moreover, Agf Incorporated has 2.26% invested in JPMorgan Chase & Co. (NYSE:JPM). Meiji Yasuda Life Insur accumulated 98,730 shares. Johnson Grp Incorporated reported 55,506 shares or 0.7% of all its holdings. Polar Capital Llp reported 0.87% in JPMorgan Chase & Co. (NYSE:JPM). Calamos Advisors Lc stated it has 1.36% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Cortland Advisers Ltd Liability owns 1.37 million shares for 6.01% of their portfolio. Rowland & Invest Counsel Adv accumulated 7,786 shares. Checchi Advisers has invested 0.31% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM).

Since August 21, 2017, it had 1 buying transaction, and 10 selling transactions for $23.24 million activity. Friedman Stacey had sold 17,729 shares worth $1.99 million. Erdoes Mary E. sold $7.31 million worth of JPMorgan Chase & Co. (NYSE:JPM) on Saturday, January 13. Petno Douglas B had sold 48,344 shares worth $5.43M. $1.84 million worth of JPMorgan Chase & Co. (NYSE:JPM) was sold by BACON ASHLEY. Scher Peter had sold 17,057 shares worth $1.91 million. Giles Nicole had sold 3,783 shares worth $425,399. Another trade for 7,280 shares valued at $825,327 was bought by CROWN JAMES S.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.